文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

EIT评估俯卧位与吸入一氧化氮对机械通气COVID-19相关ARDS的通气血流响应:一项前瞻性序贯研究

EIT-assessed ventilation-perfusion responses to prone positioning and inhaled nitric oxide in mechanically ventilated COVID-19-related ARDS: a prospective sequential study.
PubMed 文献 · J Intensive Care · 2026-07-22
一句话结论在COVID-19相关中重度ARDS中,俯卧位和iNO均改善氧合及EIT所测区域V/Q匹配,但俯卧位下iNO对V/Q匹配的改善作用减弱。

这项前瞻性序贯生理学研究纳入28例完成全部阶段的机械通气中重度COVID-19相关ARDS患者,依次评估仰卧位通气(SPV)、SPV+吸入一氧化氮(iNO 20 ppm 1 h)、俯卧位通气(PPV)及PPV+额外1 h iNO四种条件下的区域通气、灌注和V/Q匹配。结果显示SPV+iNO和PPV均较SPV改善PaO2和PaO2/FiO2,PPV+iNO进一步改善氧合并降低FiO2需求;EIT示SPV+iNO最广泛改善V/Q指标,PPV减少非灌注分数和灌注不均匀性,但PPV+iNO未进一步显著改善全局EIT V/Q指标,且局部增加背侧低V/Q区。作者结论为这些改善主要与灌注相关而非通气相关,提示成像区域可复张性有限,且俯卧位下iNO对区域V/Q匹配的效应减弱;因EIT仅采样单层胸部横截面,结果不应推广至全肺。

要点

  • 中重度COVID-19相关ARDS机械通气患者中,SPV+iNO(20 ppm 1 h)和PPV均较SPV显著提高PaO2和PaO2/FiO2,PPV+iNO进一步改善氧合并降低FiO2需求。
  • EIT显示SPV+iNO最广泛改善V/Q匹配:全局非灌注分数-7.28%、无效通气-8.14%、无效灌注-5.89%,并降低灌注全局不均匀性(GIper)。
  • PPV减少全局非灌注分数(-8.76%)和GIper,但腹背侧通气分布保持稳定;PPV+iNO未进一步显著改善全局EIT V/Q指标,反而局部增加背侧低V/Q区(+4.01%)。
  • DiD分析提示体位不显著改变iNO的急性全身氧合反应,但显著改变EIT衍生的V/Q反应,即俯卧位下iNO改善成像层面区域V/Q匹配的能力减弱。
  • EIT仅采样单层胸部横截面,上述V/Q发现为局部结果,不应推广至全肺;研究为生理学探索,非临床结局研究。

适用人群与场景

  • 机械通气的中重度COVID-19相关ARDS成人患者,28例完成全部研究阶段。
  • 研究场景为ICU床旁,评估俯卧位和吸入一氧化氮作为抢救治疗时的区域V/Q生理反应。
  • 原文未提及具体纳入/排除标准、病情阶段细节或院前场景。

诊断标准与关键阈值

  • 原文未提及ARDS诊断标准的具体条件或界值(仅描述为moderate-to-severe COVID-19-related ARDS)。
  • 研究条件为四种预设固定序贯状态:仰卧位通气(SPV)、SPV+iNO(20 ppm,1 h)、稳定后俯卧位通气(PPV)、PPV+额外1 h iNO(PPV+iNO)。
  • 原文未提及启动/停止iNO或俯卧位的临床阈值。

处置流程与药物剂量

  • 第一步:仰卧位通气(SPV)下评估基线区域通气、灌注和V/Q匹配。
  • 第二步:SPV下吸入一氧化氮20 ppm持续1 h(SPV+iNO),观察氧合和EIT V/Q指标变化。
  • 第三步:稳定后转为俯卧位通气(PPV),观察氧合和EIT V/Q指标变化。
  • 第四步:PPV下额外吸入一氧化氮1 h(20 ppm,PPV+iNO),观察氧合和EIT V/Q指标变化。
  • 原文未提及iNO的具体给药途径、停用指征、目标值或俯卧位具体时长/疗程。

红旗征与不能漏的情况

  • 原文未提及需要立刻处理或不能漏诊的红旗征及对应处理。

研究设计与关键结果

  • 研究类型:前瞻性序贯生理学研究,单中心(原文未明确多中心),样本量28例完成全部阶段。
  • 人群:机械通气的中重度COVID-19相关ARDS患者;干预与对照为四种序贯条件(SPV、SPV+iNO、PPV、PPV+iNO)的自身对照。
  • 关键结果:SPV+iNO和PPV均较SPV显著提高PaO2和PaO2/FiO2;PPV+iNO进一步改善氧合并降低FiO2需求;EIT示SPV+iNO最广泛改善V/Q指标(全局非灌注分数-7.28%、无效通气-8.14%、无效灌注-5.89%),PPV减少非灌注分数(-8.76%)和GIper。
  • 次要/探索性结果:PPV+iNO未进一步显著改善全局EIT V/Q指标,局部增加背侧低V/Q区(+4.01%);DiD示体位显著改变EIT V/Q对iNO的反应,但不显著改变全身氧合反应。
  • 不良事件:原文仅述血流动力学和常规呼吸力学在四种条件下保持稳定,未报告其他不良事件。

证据类型、等级与局限

  • 证据类型:前瞻性序贯生理学研究(自身对照设计),非RCT。
  • 局限:单中心、样本量小(28例)、EIT仅采样单层胸部横截面故为局部发现、探索性DiD分析、未报告临床结局(如死亡率、机械通气时长)。

对床旁实践的改变

  • 该研究提示:在COVID-19相关中重度ARDS中,俯卧位和iNO均可改善氧合,但俯卧位下加用iNO对EIT所测区域V/Q匹配的额外改善有限,临床决策不应仅凭氧合改善推断区域V/Q匹配同步改善。
  • EIT显示改善主要与灌注相关而非通气相关,提示成像区域可复张性有限;这一生理学信息可用于床旁理解干预机制,但EIT单层采样不能代表全肺,不适用于据此调整全肺通气策略。
  • 研究为生理学探索、样本小且无临床结局,不能据此改变俯卧位或iNO的适用人群、剂量或疗程推荐;常见陷阱是将单层EIT的局部V/Q结果外推至全肺或作为启动/停止治疗的决策阈值。

指南或共识出处

  • 原文未引用具体指南或共识名称。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Prone positioning (PP) and inhaled nitric oxide (iNO) are widely utilized rescue therapies for severe hypoxemia during invasive mechanical ventilation. However, their combined effects on regional ventilation-perfusion (V/Q) matching remain incompletely characterized. This study utilized single-plane saline-contrast electrical impedance tomography (EIT) to achieve real-time bedside visualization and evaluate the relative spatial mechanisms of these interventions in patients with COVID-19-related ARDS.

METHODS: We conducted a prospective sequential physiological study in mechanically ventilated patients with moderate-to-severe COVID-19-related acute respiratory distress syndrome (ARDS). Relative regional ventilation, perfusion, and V/Q matching distributions were monitored across four predefined, fixed sequential conditions: supine position ventilation (SPV), SPV with iNO (20 ppm for 1 h; SPV + iNO), prone position ventilation after stabilization (PPV), and PPV with an additional 1 h of iNO (PPV + iNO). Primary analyses focused on prespecified within-patient contrasts, supplemented by exploratory difference-in-differences (DiD) analyses to evaluate position-dependent vascular responses.

RESULTS: Twenty-eight patients completed all study phases. Hemodynamics and conventional respiratory mechanics remained remarkably stable across all four conditions. Systemic oxygenation improved progressively; both SPV + iNO and PPV significantly increased PaO2 and PaO2/FiO2 compared to SPV alone, while the addition of iNO during PPV (PPV + iNO) yielded further oxygenation improvements and reduced FiO2 requirements. Within the EIT-assessed thoracic slice, SPV + iNO produced the most widespread V/Q improvements, significantly reducing the global non-perfused fraction (-7.28%), wasted ventilation (-8.14%), wasted perfusion (-5.89%), and the global inhomogeneity of perfusion (GIper). Transitioning to PPV similarly reduced the global non-perfused fraction (-8.76%) and GIper, while ventral-to-dorsal ventilation distribution remained stable. Notably, while PPV + iNO improved systemic oxygenation, it did not produce additional significant reductions in global EIT V/Q metrics, and locally increased the dorsal low V/Q compartment (+ 4.01%). DiD analyses revealed that while body position did not significantly modify the acute systemic oxygenation response to iNO, it significantly altered EIT-derived V/Q responses, indicating an attenuated capacity for iNO to improve regional V/Q matching in the imaged slice when administered in the prone position.

CONCLUSIONS: Both prone positioning and iNO improved oxygenation in moderate-to-severe COVID-19-related ARDS. Within the EIT-assessed thoracic slice, these improvements were accompanied by better regional V/Q matching, which was mainly perfusion-related rather than ventilation-related and suggests limited recruitability of the imaged region; the effect of iNO on regional V/Q matching was attenuated in the prone position. As EIT samples a single thoracic cross-section, these are localized findings and should not be generalized to the whole lung. Trial registration ClinicalTrials.gov, NCT05715762. Registered 08 February 2023.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Wang Y, Dai Y, Zheng X, et al. EIT-assessed ventilation-perfusion responses to prone positioning and inhaled nitric oxide in mechanically ventilated COVID-19-related ARDS: a prospective sequential study. J Intensive Care. 2026. PMID: 42675523. doi:10.1186/s40560-026-00918-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。